# Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy

Study · id `cardio:ct-nct02488252` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02488252](<https://clinicaltrials.gov/study/NCT02488252>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02488252

Browse, organ or system: Kidneys; Metabolism  
Browse, condition area: Diabetes and metabolic disease; Kidney connections  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 148 participants.

## Technical summary

Registry record NCT02488252. Randomized; single masking; primary purpose treatment. Start 2015-07 (actual); primary completion 2021-03 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 148 participants (planned count; ClinicalTrials.gov record NCT02488252, source copy `cardio:ctgov-nct02488252-2021-04-30`, retrieved 2026-10-26)
- Started: 2015-07 (actual) (ClinicalTrials.gov record NCT02488252, source copy `cardio:ctgov-nct02488252-2021-04-30`, retrieved 2026-10-26)
- Primary completion: 2021-03 (actual) (ClinicalTrials.gov record NCT02488252, source copy `cardio:ctgov-nct02488252-2021-04-30`, retrieved 2026-10-26)
- Completion: 2021-09 (anticipated) (ClinicalTrials.gov record NCT02488252, source copy `cardio:ctgov-nct02488252-2021-04-30`, retrieved 2026-10-26)
- Countries: Hong Kong SAR China (ClinicalTrials.gov record NCT02488252, source copy `cardio:ctgov-nct02488252-2021-04-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02488252-2021-04-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy
- Acronym: SCHEMATIC
- Condition: Diabetic Nephropathies
- Intervention (Drug): Semi-individualised Chinese Medicine treatment
- Intervention (Drug): Routine medical care (active comparator)
- Lead sponsor: The University of Hong Kong
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Diabetic kidney disease (`cardio:diabetic-nephropathy`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: The University of Hong Kong (`cardio:org-the-university-of-hong-kong`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Add-on Rehmannia-6-Based Chinese Medicine in Type 2 Diabetes and CKD: A Multicenter Randomized Controlled Trial (`cardio:pubmed-37307005`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 3bfe5d62fc89eda82b7b47fc00c492c064144627f00677c42d3de456949a9c12
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
